Evidence map›Paper›PMID 28521804›Full record

Trial reportBMC veterinary research2017

Sero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination.

R M S Pimburage, M Gunatilake, O Wimalaratne, A Balasuriya, K A D N Perera

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC veterinary research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Strategies to maintain Korea's animal rabies non-occurrence status.Clinical and experimental vaccine research · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

R M S PimburageMinistry of Health, No.555/5, Elvitigala Mawatha, Colombo 05, Sri Lanka. ruwinipimburage@gmail.com.ORCID http://orcid.org/0000-0003-2737-526X
M GunatilakeDepartment of Physiology, Faculty of Medicine, University of Colombo, No.25, Kynsey Road, Colombo 08, Sri Lanka.
O WimalaratneDepartment of Rabies Research and Vaccine Quality Control, Medical Research Institute, Colombo 08, Sri Lanka.
A BalasuriyaFaculty of Medicine, General Sir John Kotelawala Defense University, Kandawala Road, Rathmalana, Sri Lanka.
K A D N PereraDepartment of Rabies Research and Vaccine Quality Control, Medical Research Institute, Colombo 08, Sri Lanka.
Medical Research Institute · LKGeneral Sir John Kotelawala Defence University · LKMinistry of Health, Nutrition and Indigenous Medicine · LKUniversity of Colombo · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMass vaccination of dogs is considered fundamental for national rabies control programmes in Sri Lanka, as dog is the main reservoir and transmitter of the disease.

methodsDogs were followed to determine the sero-prevalence of antibodies to the rabies virus. Altogether 510 previously vaccinated and unvaccinated dogs with owners (domestic dogs) and dogs without owners (stray dogs) of the local guard dog breed in different age groups recruited from Kalutara District, Sri Lanka. The dogs were vaccinated with a monovalent inactivated vaccine intramuscularly and serum antibody titres on days 0, 30, 180 and 360 were determined by the Rapid Fluorescent Focus Inhibition Test (RFFIT).

resultsThe results indicated, a single dose of anti-rabies vaccination fails to generate a protective level of immunity (0.5 IU/ml) which lasts until 1 year in 40.42% of dogs without owners and 57.14% of previously unvaccinated juvenile (age: 3 months to 1 year) dogs with owners. More than one vaccination would help to maintain antibody titres above the protective level in the majority of dogs. The pattern of antibody titre development in annually vaccinated and irregularly vaccinated (not annual) adult dogs with owners is closely similar irrespective of regularity in vaccination. Previously vaccinated animals have higher (2 IU/ml) antibody titres to begin with and have a higher antibody titre on day 360 too. They show a very good antibody titre by day 180. Unvaccinated animals start with low antibody titre and return to low titres by day 360, but have a satisfactory antibody titre by day 180.

conclusionsA single dose of anti-rabies vaccination is not sufficient for the maintenance of antibody titres for a period of 1 year in puppies, juvenile dogs with owners and in dogs without owners. Maternal antibodies do not provide adequate protection to puppies of previously vaccinated dams and puppies of previously unvaccinated dams. Immunity development after vaccination seems to be closely similar in both the groups of puppies.

Indexed as

Immunogenicity, VaccineAnimalsAntibodies, NeutralizingAntibodies, ViralDog DiseasesDogsDose-Response Relationship, ImmunologicImmunization, SecondaryRabiesRabies VaccinesSeroepidemiologic StudiesSri LankaVaccinationVaccines, InactivatedAntibodies, NeutralizingAntibodies, ViralRabies VaccinesVaccines, InactivatedAntibodyAnti-rabies vaccineDogsRFFITSero-prevalenceTitre

Identifiers

PMID28521804
PMCPMC5437496
OpenAlexW2614223704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.